Symbiotec Pharmalab IPO is set to open for subscription on August 24, 2026, giving investors an opportunity to participate in one of the upcoming mainboard IPOs. The pharmaceutical company has attracted significant institutional interest ahead of the public issue after raising ₹526.20 crore from anchor investors.
The company is looking to raise approximately ₹1,757 crore through its initial public offering. The IPO has already generated considerable market interest ahead of its opening.
Symbiotec Pharmalab IPO Details
| IPO Details | Information |
|---|---|
| IPO Name | Symbiotec Pharmalab IPO |
| IPO Type | Mainboard IPO |
| IPO Opening Date | August 24, 2026 |
| IPO Closing Date | To be confirmed from the final issue documents |
| Issue Size | Approximately ₹1,757 crore |
| Anchor Investment | ₹526.20 crore |
| Company | Symbiotec Pharmalab Limited |
| Sector | Pharmaceutical |
| IPO Status | Upcoming |
Symbiotec Pharmalab IPO Anchor Investment
Symbiotec Pharmalab has received strong institutional participation ahead of its IPO. The company raised ₹526.20 crore from anchor investors before the public issue, with prominent institutional investors participating in the anchor book.
The anchor investment is generally considered an important indicator of institutional interest, although it does not guarantee the IPO's listing performance or future returns.
Symbiotec Pharmalab IPO GMP Today
The Symbiotec Pharmalab IPO GMP (Grey Market Premium) represents the premium at which the IPO shares are reportedly being traded in the unofficial grey market before listing.
Symbiotec Pharmalab IPO GMP: ₹345
Expected Listing Price: ₹1,333
Price Band: ₹938 – ₹988
Estimated Listing Gain: Approximately 35% at the upper price band
Note: GMP is unofficial and can change frequently. Investors should not make an IPO investment decision based solely on grey market premium.
Symbiotec Pharmalab IPO Important Dates
- IPO Opens: August 24, 2026
- IPO Closes: August 27, 2026
- Allotment: Expected after the issue closes
- Listing: Expected after the allotment process
Investors should verify the final dates and issue details from the company's official IPO documents and stock-exchange disclosures before applying.
What is Symbiotec Pharmalab?
Symbiotec Pharmalab is a pharmaceutical and biotechnology company involved in the manufacturing of pharmaceutical products and active pharmaceutical ingredients (APIs). The company operates in a specialised segment of the pharmaceutical industry and has attracted investor attention ahead of its proposed public listing.
Should You Apply for Symbiotec Pharmalab IPO?
The IPO has several factors that investors may want to consider, including institutional participation and the company's position in the pharmaceutical sector. At the same time, investors should carefully evaluate the company's financial performance, valuation, business risks, industry outlook and IPO objectives before applying.
The grey market premium should only be treated as an unofficial indication of market sentiment. It is not a guaranteed listing price or return.
Symbiotec Pharmalab IPO GMP – Disclaimer
The IPO GMP mentioned above is based on information available from unofficial grey-market sources and is provided only for informational purposes. Grey market prices can change at any time and may differ significantly from the actual listing price.
GMPIPOWatch does not recommend buying or selling IPO applications in the grey market. Investors should not apply for an IPO solely based on GMP. Please conduct your own research and consult a SEBI-registered financial adviser before making investment decisions.
Keywords
Symbiotec Pharmalab IPO, Symbiotec Pharmalab IPO GMP, Symbiotec IPO GMP Today, Symbiotec Pharmalab IPO Date, Symbiotec Pharmalab IPO Price, Symbiotec Pharmalab IPO Allotment, Upcoming IPO 2026, IPO GMP Today, Mainboard IPO 2026
Loading comments...